MedPath

Proglumide

Generic Name
Proglumide
Drug Type
Small Molecule
Chemical Formula
C18H26N2O4
CAS Number
6620-60-6
Unique Ingredient Identifier
EPL8W5565D

Overview

No overview information available.

Background

No background information available.

Indication

用于治疗胃溃疡和十二指肠溃疡、胃炎等,对消化性溃疡临床的改善、溃疡愈合有较好的疗效。

Associated Conditions

  • Gastric Ulcer
  • Intestinal Inflammation
  • Intestinal ulcer
  • Gastrointestinal ulceration

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Proglumide Capsules
国药准字H51021243
化学药品
胶囊剂
9/11/2020
Proglumide Capsules
国药准字H62020247
化学药品
胶囊剂
4/10/2020
Proglumide Capsules
国药准字H11020258
化学药品
胶囊剂
12/8/2020
Proglumide Capsules
国药准字H21022223
化学药品
胶囊剂
8/18/2020
Proglumide Capsules
国药准字H32020411
化学药品
胶囊剂
8/17/2020
Proglumide Capsules
国药准字H13022404
化学药品
胶囊剂
8/13/2020
Proglumide Capsules
国药准字H32021152
化学药品
胶囊剂
8/13/2020
Proglumide Capsules
国药准字H41020769
化学药品
胶囊剂
7/23/2020
Proglumide Capsules
国药准字H45021333
化学药品
胶囊剂
9/30/2020
Proglumide Capsules
国药准字H20053353
化学药品
胶囊剂
4/9/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath